Abstract 22: Engineering KRAS-mutant-organoids from pancreatic ductal adenocarcinoma for advanced drug screening applications in-vitro and in-vivo
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Alireza Savadipour, Krishna Tummala, Eunsil Park, Vania Vidimar, Mike Veling, Mark Buchanan, Eric Muise, Gustav Hebert, Brian Long, Nicolas Solban
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409636836